Vivos (RDGL) Cash from Financing Activities (2010 - 2025)
Vivos' (RDGL) quarterly Cash from Financing Activities came in at -$845.0 in Q4 2025, down 100.06% year-over-year from $1.5 million in Q4 2024, and down 100.06% quarter-over-quarter from $1.5 million in Q1 2025.
Analysis
Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Vivos has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$845.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 100.06% year-over-year to -$845.0; the TTM figure through Dec 2025 stood at $1.5 million (down 34.6% YoY), while the FY2025 annual figure was $1.5 million, down 34.6% from the prior year.
- Cash from Financing Activities came in at -$845.0 for Q4 2025 at Vivos, down from $1.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
- Average Cash from Financing Activities over 4 years is $667335.9, with a median of $518580.0 recorded in 2023.
- The largest YoY upside for Cash from Financing Activities was 2420.16% in 2021 against a maximum downside of 111.56% in 2021.
- Over 4 years, Cash from Financing Activities stood at -$145000.0 in 2021, then surged by 457.64% to $518580.0 in 2023, then jumped by 182.56% to $1.5 million in 2024, then tumbled by 100.06% to -$845.0 in 2025.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$845.0 in Q4 2025, $1.5 million in Q1 2025, and $1.5 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -845.00 |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 518,580.00 |
| Sep 30, 2023 | 10,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Mar 31, 2021 | 1.81 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | 482,910.00 |
| Mar 31, 2020 | 71,870.00 |
| Dec 31, 2019 | 115,000.00 |
| Sep 30, 2019 | 335,000.00 |
| Jun 30, 2019 | 94,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Dec 31, 2018 | 538,140.00 |
| Sep 30, 2018 | 70,932.00 |
| Jun 30, 2018 | 48,559.00 |